14th European and Global CLINAM Summit

The 14^th European and Global CLINAM-Summit will take place from October 8 to October 11, 2023, in Basel/Switzerland: "Crossing the Horizon towards novel Possibilities, Existing and Evolving Products, Technologies, Research and Strategies for Global Health".

Download the Preliminary Programme.

Introduction

The non-profit European Foundation for Clinical Nanomedicine will have after two virtual Summits in 2020 & 2022 its 14^th Summit as a hybrid event with personal attendance and live stream.

CLINAM 14 /2023 will be the unique traditional platform with a scientific programme that will elucidate the state of the art of Nanomedicine in Production, Development and at Clinic for Prevention, Diagnosis and Therapy. In particular, since the development of mRNA vaccines based on lipid nanoparticles (LNPs), nanomedicine has received huge awareness and has matured by now to a boosting field with highest recognition. This is the right moment to review the development of the technology as well as looking at the products and their use in clinical medicine to the benefit of patients. The achievement of the revolutionary protective wall against COVID -19 by mRNA vaccines predicts a profound acceleration of innovative drug development to the benefit of patients.

However not for all humankind: A strong focus shall be, to enable and improve health care in countries where therapy until today is unaffordable or absent. Further, the delivery of drugs by different nanoparticles shall be an important issue. All stakeholders in the field, including many high-ranking scientists, Nobel Laureates and leading managers and regulatory authorities from all continents exploit the CLINAM-summit since 15 years for new projects and making bonds for cooperation. They all contribute to an excellent scientific outlook.

For 2023, CLINAM addressed three outstanding organizers of excellent conferences and invited them to participate with a session within the CLINAM-Summit. The different skills of the parties will give a great unique interdisciplinary perspective on nanomedicine and related fields in Europe
and on international level.

These organisations are:

• The International Association for Pharmaceutical Technology (APV)
• The Liposomes Research Days (LRD)
• The Phospholipid Research Center Heidelberg (PRC)

Scientific Committee of the Summit 2023

• Prof. Dr. med. Patrick Hunziker, University Hospital Basel (CH)
• Prof. Dr. Lajos Balogh, Editor-in-Chief, Precision Nanomedicine, Boston (USA)
• Prof. Dr. Yechezkel Barenholz, Professor Emeritus, Head of Membrane and Liposome Research Lab, Hebrew University Hadassah Medical School, Jerusalem (IL)
• Prof. Dr. Dr. Twan Lammers, Institute for Experimental Molecular Imaging, RWTH Aachen (DE)
• Prof. Dr. med. Dong Soo Lee, Ph.D. Chairman, Department of Nuclear Medicine Seoul National University, Seoul (KOR)
• Dr. med. h.c. Beat Löffler, MA, CEO, CLINAM Foundation, Basel (CH)
• Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, Utrecht (NL)
• Prof. Dr. Dr. h.c. Viola Vogel, Head of the Laboratory of Applied Mechanobiology, Department for Health Sciences and Technology (HEST), ETH, Zürich (CH)
• PD Dr. Peter van Hoogevest, Member of the Scientific Advisory Council, Phospholipid Research Center, Heidelberg (DE)
• Prof. Dr. med. Raymond Schiffelers, Professor of Nanomedicine; Division LAB CDL Research; UMC Utrecht, Chairman of the ETP Nanomedicine Executive Board, Utrecht (NL)
• PD Dr. habil. Simon Drescher, Managing Director, Phospholipid Research Center, Heidelberg (DE)
• Prof. Dr. Theresa Allen, University of Alberta, University of British Columbia and Organizer of the Lipid Research Days 2022, Vancouver (CAN)
• Prof. Dr. Pieter Cullis, Professor of Biochemistry, University of B.C. (UBC) Vancouver, Cofounder of Acuitas Therapeutics, lipid nanoparticle technology, Vancouver (CAN)
• Dr. Martin Bornhöft, Head of the International Association for Pharmaceutical Technology (APV), Mainz (DE)